Loading page
Loading page
Loading substance route
It is recommended to perform a cold water extraction if the product combines dihydrocodeine with acetaminophen or other substances to isolate the active opioid.
Effects vary widely by individual, dose, and context.
The physical effects of dihydrocodeine can be broken down into several components which progressively intensify proportional to dosage.
The cognitive effects of dihydrocodeine can be broken down into several components which progressively intensify proportional to dosage. The general head space of dihydrocodeine is described by many as one of intense euphoria, relaxation, anxiety suppression and pain relief.
These combinations are considered extremely harmful and should always be avoided. Reactions to these drugs taken in combination are highly unpredictable and have a potential to cause death.
There is considerable risk of physical harm when taking these combinations, they should be avoided where possible.
These combinations are not usually physically harmful, but may produce undesirable effects, such as physical discomfort or overstimulation. Extreme use may cause physical health issues. Synergistic effects may be unpredictable. Care should be taken when choosing to use this combination.
Dihydrocodeine produces euphoria at higher-than-therapeutic doses and is commonly used recreationally. Psychological dependence develops with repeated use, as is characteristic of opioids.
Physical dependence develops with repeated use. Dihydrocodeine has demonstrated cross-tolerance with other opioids and has historically been used to manage morphine withdrawal.
Dihydrocodeine is a semi-synthetic opioid that was developed in Germany in 1908 during a period of intensive research into more effective antitussive agents. This effort was motivated by the urgent need to limit the transmission of airborne infectious diseases, particularly tuberculosis, pertussis,…
Available without prescription in over-the-counter cough preparations such as cough syrups. Represents a notable exception in global drug policy where dihydrocodeine remains accessible for consumer purchase without a medical prescription.
11 sources cited
